Trastuzumab duocarmazine by Byondis for Gastric Cancer: Likelihood of Approval

Trastuzumab duocarmazine is under clinical development by Byondis and currently in Phase I for Gastric Cancer.

Dementia and Sleep; Functional Neurologic Disorder and Long COVID; Autism-Gut Link?

The New York Times examined the complicated relationship between sleep and dementia. While a U.K. Biobank study looked at how sleep, chronotype, and other factors

July 17, 2024

Patients with asthma and other inflammatory lung diseases can be treated ‘in a fundamentally new way’

Arrowhead Pharmaceuticals Inc. has announced interim results from an ongoing phase 1/2 clinical study of ARO-RAGE, an investigational RNA interference (RNAi) therapeutic designed to reduce

April 27, 2023

World’s first comparative study shows safety of single-port robotic thymectomy

A Joint research team (Prof. Jun-hee Lee, Hyun-koo Kim, Jin-Wook Hwang, Jae-Ho Chung, the Department of Thoracic and Cardiovascular Surgery, Korea University College of Medicine)

November 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.